NIH-funded research R21 grant

Understanding how lysosome damage contributes to liver disease from alcohol use

Official title: Role of Lysosome Damage in ALD Pathogenesis

Funded at Auburn University at Auburn · NIH-10990752 · Data updated 2026-11-12

This study is looking at how drinking alcohol affects liver cells, especially how it damages tiny structures called lysosomes, which can lead to liver problems; the goal is to find new ways to treat or prevent alcohol-related liver disease.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionAuburn University at Auburn
NIH-funded
Lab location1 site (Auburn, UNITED STATES)
Project startMay 15, 2024
Project endAugust 31, 2025
Funding year2023
Award (this year)$402,937
NIH project number7R21AA030333-02
Project IDNIH-10990752 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a history of heavy alcohol consumption who are experiencing liver-related health issues.

Less likely to help

Patients who do not consume alcohol or have liver disease due to non-alcoholic causes may not benefit from this research.

What this research studies

This research investigates the cellular and molecular changes that occur in the liver due to alcohol consumption, particularly focusing on how damage to lysosomes affects liver health. The study aims to identify specific alterations caused by alcohol metabolites that lead to lysosome damage in liver cells, which can result in cell death and inflammation. By understanding these mechanisms, the research seeks to uncover potential new treatment targets for alcohol-associated liver disease (ALD). The findings could help improve disease prognosis and develop therapies to prevent or alleviate ALD.

Why it matters

Potential benefit: If successful, this research could lead to new treatment options for patients suffering from alcohol-associated liver disease.

How similar studies have gone: While there has been some research on liver damage due to alcohol, the specific focus on lysosome damage in this context is relatively novel and untested.

Where this research is happening

  • Auburn University at Auburn
    Auburn, United States
    Active

Researchers

  • Principal investigator: Thomes, Paul Gideon — Auburn University at Auburn
  • Study coordinator: Thomes, Paul Gideon

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.